TareBio
<!-- hacklab:yc-profile -- YC company profile Vaccines for any cancer or infection in weeks. Our platform develops personalized or population-level vaccines for any disease in w…
About TareBio
YC company profile
Vaccines for any cancer or infection in weeks.
Our platform develops personalized or population-level vaccines for any disease in weeks by changing only one input: the immune imprint. Instead of trying to predict which antigens might work, we read out immune cells already fighting the disease in the body and reverse-engineer antigens that activate them. We've already run our platform end-to-end and created a vaccine that cured cancer in mice.
- YC batch: Summer 2026
- Founded: 2026
- Team size: 1
- Location: San Francisco
- Country: US
- Status: Active
- Industry: Healthcare
- Stage: Early
- Tags: Vaccines, Synthetic Biology, Biotechnology
- YC partner: Ankit Gupta
Founders
Eta Atolia — Founder/CEO
Founder & CEO, TareBio (YC S26). MD-PhD from UCLA-Caltech, where she built a novel platform that develops vaccines for any cancer or infection in weeks, funded by the Gates Foundation. BS in Biology from MIT. Conducted research at the Koch Institute, Harvard Medical School, and the Weizmann.
Select Awards: UCLA MD-PhD Merit Scholar, UCLA TDG Senior Fellow, MIT iGEM Gold Medal, MIT IDEAs winner, MIT Dean Advisory Group, WhiteHouse Science Fair, Bessie Lawrence Scholar, Intel STS Finalist
Source: Y Combinator · Retrieved 2026-11-02. Company information is self-reported on YC.